News in brief - August 2013

Other new launches, licence changes and updates relevant to general practice.

Nipatra is a mint-flavoured chewable tablet formulation of sildenafil for erectile dysfunction.
Nipatra is a mint-flavoured chewable tablet formulation of sildenafil for erectile dysfunction.
  • A chewable tablet formulation of sildenafil (Nipatra) is now available for the treatment of erectile dysfunction.
  • Ditropan Elixir (oxybutynin) has been relaunched by Sanofi for the treatment of urinary frequency, urgency and urge incontinence and neurogenic bladder disorders. and for the treatment of nocturnal enuresis in children when other treatment has failed.
  • The licence for Strattera (atomoxetine) has been extended to include initiation of treatment in adults with ADHD when the presence of symptoms in childhood can be confirmed.
  • RoActemra (tocilizumab) can now be used in the management of juvenile idiopathic polyarthritis in children who have responded inadequately to previous therapy with methotrexate.
  • Amdipharm Mercury has launched Ampres (chloroprocaine), a spinal anaesthetic for use where the planned procedure should not exceed 40 minutes.
  • Patients with transfusion-dependent anaemia due to myelodysplastic syndromes associated with an isolated 5q deletion can now benefit from treatment with Revlimid (lenalidomide) when other treatments are unsuitable.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases